Oncology

Optimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients With
Conditions: Tumor Infiltrating Lymphocyte; CD8-PET; Advanced Melanoma

Interventions: Drug: Crefmirlimb; Device: PET/CT imaging

Sponsors: M.D. Anderson Cancer Center; ImaginAb, Inc.

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 16, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
Conditions: Platinum-sensitive Relapsed Epithelial Ovarian Cancer; Platinum-sensitive Relapsed Fallopian Tube Cancer; Platinum-sensitive Relapsed Primary Peritoneal Cancer

Interventions: Drug: Torvutatug samrotecan; Drug: Bevacizumab

Sponsors: AstraZeneca; GOG Foundation; European Network of Gynaecological Oncological Trial Groups (ENGOT); Ventana Medical Systems, Inc

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 15, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
A Study of SX-682 in Combination With Proton Craniospinal Irradiation (pCSI) in People With Leptomeningeal Disease
Conditions: Leptomeningeal Disease (LMD)

Interventions: Drug: SX-682; Radiation: Proton Craniospinal Irradiation (pCSI)

Sponsors: Memorial Sloan Kettering Cancer Center; National Comprehensive Cancer Network; Syntrix Pharmaceuticals

**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 14, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma
Conditions: Metastatic Urothelial Carcinoma; Metastatic Urothelial Carcinoma (UC)

Interventions: Drug: Ivonescimab Dose 1; Drug: enfortumab vedotin (EV); Drug: Pembrolizumab; Drug: Ivonescimab Dose 2; Drug: Ivonescimab RP3D

Sponsors: Summit Therapeutics

**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 13, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
Targeting Immune Modulation in High Grade Serous Carcinoma: Combined Effects of Chemotherapy and Atorvastatin
Conditions: Ovarian Cancer; Fallopian Tube Cancers; Primary Peritoneal Cancer; High Grade Serous Adenocarcinoma of Ovary

Interventions: Drug: Standard of Care + atorvastatin; Drug: Standard of Care (SOC)

Sponsors: University of Colorado, Denver

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 12, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer
Conditions: Grade 1 Endometrial Endometrioid Carcinoma; Endometrial Intraepithelial Neoplasia; Metabolic Comorbidities

Interventions: Drug: Tirzepatide

Sponsors: Milton S. Hershey Medical Center

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 11, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
Prevention of Oral Mucositis in Adults in With Hematologic Malignancy
Conditions: Acute Leukemia; Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Oral Mucositis

Interventions: Dietary Supplement: Aloe Vera Mouthwash; Other: Standard of Care

Sponsors: Wake Forest University Health Sciences

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 10, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
Conditions: Colon Cancer; Microsatellite Stable (MSS) Colon Cancer; Proficient Mismatch Repair (pMMR) Colon Cancer

Interventions: Drug: Pembrolizumab; Drug: Porustobart

Sponsors: Solstice Oncology, Inc.

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 9, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
Intraparenchymal Salivary Gland Corticosteroid Injection to Prevent Radiation-Induced Xerostomia
Conditions: Xerostomia; Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Dexamethasone 4mg/mL; Drug: Dexamethasone 10mg/mL

Sponsors: University of California, Davis

Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 8, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
Community Enhanced Virtual Informed Consent
Conditions: Hematopoietic and Lymphatic System Neoplasm; Malignant Solid Neoplasm

Interventions: Behavioral: Behavioral Intervention; Other: ICF Text Version 1; Other: ICF Text Version 2; Other: ICF Video Version 1; Other: ICF Video Version 2; Other: ICF Video Version 3; Other: ICF Video Version 4; Other: Survey Administration

Sponsors: Mayo Clinic

**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 7, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Read more 
Free Clinical Trial Updates

    #1 Best New Product in 2019
    Headache Relief Shampoo Banner Ad
    Search For Clinical Trials
      CLOSE
      Please click to geolocate button to change this value.
      SEARCHRESET
      Featured Research Centers